SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form C/A - Offering Statement: [Amend]
SEC Accession No. 0001669191-19-000005
Filing Date
2019-01-04
Accepted
2019-01-03 17:49:43
Documents
9

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C/A  
1 primary_doc.xml C/A 9840
2 OFFERING STATEMENT PDF offeringstatement.pdf EX-99 136440
3 OFFERING PAGE JPG offeringpage.jpg GRAPHIC 3209398
4 CPA REVIEW REPORT reviewletter.pdf EX-99 124107
5 CERTIFICATE OF FORMATION certificateofformation.pdf EX-99 441614
6 OPERATING AGREEMENT operatingagreement.pdf EX-99 2857615
7 PITCH DECK pitchdeck.pdf EX-99 2636148
8 ADDITIONAL INFORMATION otherfinancial.pdf EX-99 82500
9 IMAGE ATTACHMENTS HTML imageattachments.htm EX-99 244
  Complete submission text file 0001669191-19-000005.txt   13064669
Mailing Address 3-E GILL STREET WOBURN MA 01801
Business Address 3-E GILL STREET WOBURN MA 01801 7819326933
Aphios Pharma LLC (Filer) CIK: 0001750795 (see all company filings)

IRS No.: 820903443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C/A | Act: 33 | File No.: 020-24655 | Film No.: 19507381